共 50 条
In vivo timing of onset of transgene expression following adenoviral-mediated gene transfer
被引:10
|作者:
Dumasius, V
Jameel, M
Burhop, J
Meng, FJ
Welch, LC
Mutlu, GM
Factor, P
机构:
[1] Evanston Northwestern Healthcare, Pulm & Crit Care Med Sect, Evanston, IL 60201 USA
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
来源:
关键词:
adenovirus;
onset;
gene therapy;
lung;
pseudotransduction;
beta(2)-adrenergic receptor;
alveolar fluid clearance;
D O I:
10.1016/S0042-6822(02)00138-1
中图分类号:
Q93 [微生物学];
学科分类号:
071005 ;
100705 ;
摘要:
Recombinant adenoviruses are efficient gene transfer vehicles that could be used for treatment of acute diseases. However, the time required for adenoviruses to produce physiologically relevant levels of transgene in vivo is unknown. To address this question rat lungs were infected with an E1a(-)/E3a(-) adenovirus that contains an hCMV-driven human beta(2)-adrenergic receptor (beta(2)AR) cDNA. Human beta(2)AR message and protein expression were noted 2-4 h postinfection without evidence of pseudotransduction. beta(2)AR function (CAMP production) was increased at 6 h postinfection. To determine when beta(2)AR gene transfer affects downstream catecholamine-sensitive pathways, we measured lung Na,K-ATPase expression and alveolar fluid clearance (AFC). beta(2)AR gene transfer increased Na,K-ATPase number by 80% at 6 h, and AFC by 20% at 8 h postinfection. These data indicate that recombinant adenoviruses can produce physiologically significant levels of transgene within hours of infection and that they may be suitable for gene therapies for acute, rapidly progressive diseases. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:243 / 249
页数:7
相关论文